Compliance in Clinical Research Operations

MAGI 2024: The Clinical Research Conference

Please let us know what you thought of this session.

Question Title

* 1. Please give an overall rating for this session.
1 Star = Poor | 4 Stars = Excellent

Poor

Below Average

Above Average

Excellent

Poor

Below Average

Above Average

Excellent

Question Title

* 2. Did the session meet the specified session description?

Yes

No

Question Title

* 3. The speaker was well prepared.

	Strongly disagree	Disagree	Agree	Strongly agree
• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Strongly disagree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Disagree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Agree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Strongly agree
• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Strongly disagree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Disagree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Agree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Strongly agree
• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Strongly disagree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Disagree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Agree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Strongly agree

Question Title

* 4. The speaker communicated their content effectively.

	Strongly disagree	Disagree	Agree	Strongly agree
• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Strongly disagree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Disagree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Agree	• Lawrence Yarmaloff - Principal Consultant - Panacea Clinical Research Strongly agree
• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Strongly disagree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Disagree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Agree	• Jeanna Julo - Quality Improvement & Compliance Officer - Office of Clinical Trial Activation, University of California, San Francisco Strongly agree
• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Strongly disagree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Disagree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Agree	• Jennifer Peterson - Director, Head of Clinical Quality - M3 Wake Research Strongly agree

Question Title

* 5. How can the organizers and speakers improve this session in the future?